Acitretin
An oral retinoid medication derived from vitamin A that is used to treat severe psoriasis and other serious skin disorders by regulating abnormal skin cell growth and reducing inflammation. It is highly effective for pustular and erythrodermic psoriasis but requires strict pregnancy prevention because it causes severe birth defects; women must avoid pregnancy for three years after stopping treatment. Regular blood tests to monitor liver function and blood lipid levels are essential during therapy.
分子量
326.4000 g/mol
LogP
6.10
TPSA
46.50 Ų
Lipinski 五规则
符合
治疗领域
作用机制
Serves as an essential micronutrient cofactor in various enzymatic reactions and metabolic processes. Supplementation corrects deficiency states and supports normal physiological function.
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Serves as an essential micronutrient cofactor in various enzymatic reactions and metabolic processes. Supplementation corrects deficiency states and supports normal physiological function.
二维结构
Cite this structure
Embed this structure
SMILES
COc1cc(C)c(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)c(C)c1C
InChI
InChI=1S/C21H26O3/c1-14(8-7-9-15(2)12-21(22)23)10-11-19-16(3)13-20(24-6)18(5)17(19)4/h7-13H,1-6H3,(H,22,23)/b9-7+,11-10+,14-8+,15-12+
Molecular Formula
C21H26O3
HBD / HBA
1 / 3
可旋转键数
6
重原子数
24
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
常见问题
An oral retinoid medication derived from vitamin A that is used to treat severe psoriasis and other serious skin disorders by regulating abnormal skin cell growth and reducing inflammation. It is highly effective for pustular and erythrodermic psoriasis but requires strict pregnancy prevention because it causes severe birth defects; women must avoid pregnancy for three years after stopping treatment. Regular blood tests to monitor liver function and blood lipid levels are essential during therapy.
Serves as an essential micronutrient cofactor in various enzymatic reactions and metabolic processes. Supplementation corrects deficiency states and supports normal physiological function.
Yes, Acitretin is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1131. Open-access bioactivity database.
- PubChem — National Center for Biotechnology Information (NCBI). CID 5284513. Chemical information database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="acitretin"></div>Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/acitretin/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/acitretin/Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/acitretin/)Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="acitretin"></drugfyi-drug>